Efficacy and safety of everolimus as long-term treatment in Japanese patients with advanced pancreatic neuroendocrine tumours.
Phase of Trial: Phase II
Latest Information Update: 12 Aug 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Neuroendocrine tumours; Pancreatic cancer
- Focus Therapeutic Use
- 12 Aug 2015 New trial record